These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36262035)

  • 1. Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis.
    Durham DD; Abraham LA; Roberts MC; Khan CP; Smith RA; Kerlikowske K; Miglioretti DL
    Cancer; 2022 Dec; 128(24):4232-4240. PubMed ID: 36262035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort.
    Braithwaite D; Miglioretti DL; Zhu W; Demb J; Trentham-Dietz A; Sprague B; Tice JA; Onega T; Henderson LM; Buist DSM; Ziv E; Walter LC; Kerlikowske K;
    JAMA Intern Med; 2018 Apr; 178(4):494-501. PubMed ID: 29435563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age at initiation of screening mammography by family history of breast cancer in the breast cancer surveillance consortium.
    Durham DD; Roberts MC; Khan CP; Abraham LA; Smith RA; Kerlikowske K; Miglioretti DL
    Cancer Causes Control; 2021 Jan; 32(1):103-107. PubMed ID: 33098534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Trends in Family History of Breast Cancer and Associated Risk.
    Shiyanbola OO; Arao RF; Miglioretti DL; Sprague BL; Hampton JM; Stout NK; Kerlikowske K; Braithwaite D; Buist DSM; Egan KM; Newcomb PA; Trentham-Dietz A
    Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1753-1760. PubMed ID: 28986348
    [No Abstract]   [Full Text] [Related]  

  • 5. Performance of screening mammography among women with and without a first-degree relative with breast cancer.
    Kerlikowske K; Carney PA; Geller B; Mandelson MT; Taplin SH; Malvin K; Ernster V; Urban N; Cutter G; Rosenberg R; Ballard-Barbash R
    Ann Intern Med; 2000 Dec; 133(11):855-63. PubMed ID: 11103055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
    Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
    Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity.
    Miglioretti DL; Bissell MCS; Kerlikowske K; Buist DSM; Cummings SR; Henderson LM; Onega T; O'Meara ES; Rauscher GH; Sprague BL; Tosteson ANA; Wernli KJ; Lee JM; Lee CI
    JAMA Netw Open; 2021 Mar; 4(3):e211974. PubMed ID: 33764423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: A nationwide cohort study.
    Mukama T; Kharazmi E; Sundquist K; Sundquist J; Fallah M
    Cancer; 2021 Jun; 127(12):2091-2098. PubMed ID: 33620751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
    Schousboe JT; Kerlikowske K; Loh A; Cummings SR
    Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of invasive breast cancer in relatives of patients with breast carcinoma in situ: a prospective cohort study.
    Mukama T; Fallah M; Brenner H; Xu X; Sundquist K; Sundquist J; Kharazmi E
    BMC Med; 2020 Nov; 18(1):295. PubMed ID: 33148280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-Adapted Starting Age of Screening for Relatives of Patients With Breast Cancer.
    Mukama T; Kharazmi E; Xu X; Sundquist K; Sundquist J; Brenner H; Fallah M
    JAMA Oncol; 2020 Jan; 6(1):68-74. PubMed ID: 31725845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening Performance of Digital Breast Tomosynthesis vs Digital Mammography in Community Practice by Patient Age, Screening Round, and Breast Density.
    Lowry KP; Coley RY; Miglioretti DL; Kerlikowske K; Henderson LM; Onega T; Sprague BL; Lee JM; Herschorn S; Tosteson ANA; Rauscher G; Lee CI
    JAMA Netw Open; 2020 Jul; 3(7):e2011792. PubMed ID: 32721031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer risk characteristics of women undergoing whole-breast ultrasound screening versus mammography alone.
    Sprague BL; Ichikawa L; Eavey J; Lowry KP; Rauscher G; O'Meara ES; Miglioretti DL; Chen S; Lee JM; Stout NK; Mandelblatt JS; Alsheik N; Herschorn SD; Perry H; Weaver DL; Kerlikowske K
    Cancer; 2023 Aug; 129(16):2456-2468. PubMed ID: 37303202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of breast cancer from screening women according to predicted family history risk: Does annual clinical examination add to mammography?
    Gui GP; Hogben RK; Walsh G; A'Hern R; Eeles R
    Eur J Cancer; 2001 Sep; 37(13):1668-73. PubMed ID: 11527694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study.
    FH01 collaborative teams
    Lancet Oncol; 2010 Dec; 11(12):1127-34. PubMed ID: 21093374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
    Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
    Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.
    Miller AB; Wall C; Baines CJ; Sun P; To T; Narod SA
    BMJ; 2014 Feb; 348():g366. PubMed ID: 24519768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer risk.
    Tilanus-Linthorst MM; Lingsma HF; Evans DG; Thompson D; Kaas R; Manders P; van Asperen CJ; Adank M; Hooning MJ; Kwan Lim GE; Eeles R; Oosterwijk JC; Leach MO; Steyerberg EW
    Int J Cancer; 2013 Jul; 133(1):156-63. PubMed ID: 23292943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline.
    Wernli KJ; Arao RF; Hubbard RA; Sprague BL; Alford-Teaster J; Haas JS; Henderson L; Hill D; Lee CI; Tosteson ANA; Onega T
    J Womens Health (Larchmt); 2017 Aug; 26(8):820-827. PubMed ID: 28177856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.